Insilico Medicine
See 5 documented AI implementations at Insilico Medicine. Real case studies with metrics and ROI data from pharmaceutical & life science.
Pharmaceutical & Life Science · Startup · 5 AI implementations
Insilico Medicine is a startup pharmaceutical & life science medicine company with 5 documented AI implementations spanning Drug Discovery & Development. Their AI initiatives focus on Drug Discovery & Development using Large Language Models & Generative AI.
Insilico Medicine is also an AI vendor in medicine. View their vendor profile and the case studies they've powered →
5
Case Studies
1
Use Case Types
1
Technologies
AI implementations at Insilico Medicine
I
Insilico Medicine
Insilico Medicine's AI-generated drug INS018_055 enters Phase II human clinical trials for idiopathic pulmonary fibrosis
Pharmaceutical & Life ScienceDrug Discovery & DevelopmentLarge Language Models & Generative AI
Insilico Medicine
Insilico Medicine discovers IPF drug candidate ISM001-055 in 18 months for $2M using generative AI
Pharmaceutical & Life ScienceDrug Discovery & DevelopmentLarge Language Models & Generative AI
I
Insilico Medicine
Insilico Medicine's Generative AI Platform Designs TNIK Inhibitor That Achieves Positive Phase 2a Results for IPF in 18-Month Discovery Timeline
Pharmaceutical & Life ScienceDrug Discovery & DevelopmentLarge Language Models & Generative AI
I
Insilico Medicine
Insilico Medicine reaches Phase 2a clinical milestone with generative AI-designed TNIK inhibitor for IPF in under 30 months
Pharmaceutical & Life ScienceDrug Discovery & DevelopmentLarge Language Models & Generative AI
I
Insilico Medicine
Insilico Medicine cuts drug discovery timeline to 12-18 months with generative AI platform Chemistry42, advancing ISM3412 cancer drug to Phase 1 trial
Pharmaceutical & Life ScienceDrug Discovery & DevelopmentLarge Language Models & Generative AI
AI Roadmap — Two hours charting for every hour with patients. Prior auth eating your back office. Both fixable, in the right order. 12 pages, 72 hours.